RANIERI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 6.590
EU - Europa 6.540
AS - Asia 4.254
SA - Sud America 540
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 5
Totale 17.987
Nazione #
US - Stati Uniti d'America 6.501
CN - Cina 1.735
IE - Irlanda 1.645
SG - Singapore 1.347
UA - Ucraina 1.099
SE - Svezia 853
IT - Italia 841
DE - Germania 589
RU - Federazione Russa 500
BR - Brasile 466
FI - Finlandia 372
HK - Hong Kong 371
FR - Francia 280
IN - India 271
TR - Turchia 246
GB - Regno Unito 140
VN - Vietnam 140
CZ - Repubblica Ceca 60
CA - Canada 51
NL - Olanda 39
BE - Belgio 31
AT - Austria 27
JP - Giappone 26
MX - Messico 26
ES - Italia 23
AR - Argentina 19
ZA - Sudafrica 19
BD - Bangladesh 16
PL - Polonia 15
EC - Ecuador 13
CL - Cile 12
LT - Lituania 11
PK - Pakistan 11
PY - Paraguay 10
EU - Europa 9
ID - Indonesia 9
IQ - Iraq 9
PH - Filippine 8
UZ - Uzbekistan 8
VE - Venezuela 8
AZ - Azerbaigian 7
MA - Marocco 7
IR - Iran 6
JO - Giordania 6
MY - Malesia 6
CO - Colombia 5
IL - Israele 5
RO - Romania 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
NZ - Nuova Zelanda 3
OM - Oman 3
AU - Australia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
NG - Nigeria 2
NP - Nepal 2
PE - Perù 2
SY - Repubblica araba siriana 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MW - Malawi 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.987
Città #
Dublin 1.645
Chandler 999
Jacksonville 772
Singapore 640
Nyköping 548
Dearborn 541
Ashburn 417
Munich 412
Nanjing 380
Hong Kong 366
Beijing 313
Dallas 242
Wilmington 239
New York 224
Santa Clara 212
Helsinki 203
Princeton 179
San Mateo 157
Nanchang 145
Ann Arbor 122
Boardman 119
Foggia 98
Moscow 96
Shenyang 85
Woodbridge 83
Bari 73
Des Moines 73
The Dalles 70
Tianjin 69
Hebei 68
Los Angeles 68
Milan 55
Brno 53
Ho Chi Minh City 53
Seattle 53
Kunming 51
Rome 46
Jiaxing 45
Changsha 43
Pune 36
São Paulo 35
Hangzhou 33
Jinan 30
Brussels 29
Falls Church 29
Guangzhou 28
Hanoi 28
Shanghai 28
Brooklyn 25
Hilden 25
Zhengzhou 25
Ningbo 23
Tokyo 23
Toronto 23
San Francisco 22
Augusta 20
London 18
Noci 17
Norwalk 17
Rio de Janeiro 17
Taizhou 17
Changchun 16
Lanzhou 16
Fuzhou 15
Stevenage 15
Belo Horizonte 14
Naples 14
Auburn Hills 13
Houston 13
Manfredonia 13
Chicago 12
Warsaw 12
Nuremberg 11
Turku 11
Vienna 11
Boston 10
Catania 10
Florence 10
Phoenix 10
Saint Petersburg 10
Atlanta 9
Falkenstein 9
Johannesburg 9
Jyväskylä 9
Leawood 9
Orange 9
Rotterdam 9
Shenzhen 9
Wuhan 9
Bologna 8
Düsseldorf 8
Latina 8
Manchester 8
Molfetta 8
Redwood City 8
Stockholm 8
Washington 8
Acquaviva Delle Fonti 7
Baku 7
Bisceglie 7
Totale 11.007
Nome #
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 410
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 260
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 253
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression 238
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 227
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 167
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 150
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 149
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 148
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 147
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 147
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 144
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 144
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 141
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 140
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 137
cell carcinoma cell line and use thereof. 135
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 132
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 132
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 129
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 129
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 129
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 124
IgA nephropathy: pros and cons for a familial disease. 123
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 123
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 123
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 122
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 122
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 122
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 121
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 121
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 121
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 121
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 118
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 118
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 116
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 116
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 115
Renal cortical complement C3 gene expression in IgA nephropathy 115
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 114
Renal Carcinoma Cell Line and Use Thereof 114
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 113
Biosimilar: can we manage biopharmaceutical heterogeneity? 112
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 111
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 110
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 110
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 110
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 107
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 107
Linea cellulare di carcinoma renale e suo uso 107
Reclassification of glomerulopathies: which role for the podocyte? 106
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 106
Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: Description of an optimized gel-based protocol 106
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 105
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 105
Altered expression of the clock gene machinery in kidney cancer patients 105
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 104
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 104
Renal and upper urinary tract tumors: what the nephrologist should know 103
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 103
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 103
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 103
Salivary proteomic signatures of oral squamous cell carcinoma. 103
Diagnostic and prognostic markers of renal cell carcinoma 103
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 103
Immunologic Response to RCC. 102
Urinary epidermal growth factor concentration in patients affected by ADPKD. 102
Altered phosphorylation of cytoskeleton proteins in peripheral blood mononuclear cells characterizes chronic antibody-mediated rejection in kidney transplantation 102
Is Berger's disease a hereditary nephritis? 101
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 101
Growth factors and their receptors in the progression of renal damage. 101
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 100
Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG) 100
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 98
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 98
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 98
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 96
Cytotoxic T-Cells Methods and Protocols Preface 96
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 96
Monitoring biological action of rapamycin in renal transplantation. 95
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA) 95
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 94
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 94
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 94
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 93
Diabetes Mellitus (DM) reduces survival in patients with renal cell carcinoma (RCC) : role of OGG1 and tuberine 93
CD40 cross-linking induces migration of renal tumor cell through nuclear factor of activated T cells (NFAT) activation 93
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 92
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 92
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 91
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 91
VHL gene alterations in Italian patients with isolated renal cell carcinomas. 91
TLR7 and TLR8 as targets for tumor immunotherapy 91
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 90
TGF-β promotes immune suppression by inhibiting Treg cell apoptosis 90
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 90
CTL ELISPOT AssayCytotoxic T-Cells 90
Platelet-derived growth factor and proliferative glomerulonephritis. 89
PROTEOMIC PROFILE OF CD24+CD133+RENAL MULTIPOTENT PROGENITORS (RMP) 89
Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine 89
Totale 11.923
Categoria #
all - tutte 101.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.767


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021958 0 0 0 0 0 114 222 43 295 263 17 4
2021/20221.139 157 14 16 33 119 46 41 79 187 139 39 269
2022/20234.250 372 177 237 274 257 365 42 312 1.957 54 88 115
2023/20241.056 120 34 49 23 73 387 58 87 17 14 14 180
2024/20253.415 196 47 113 103 125 454 484 268 815 175 335 300
2025/20262.400 325 511 559 693 278 34 0 0 0 0 0 0
Totale 18.497